Verve Therapeutics
VERV
#7385
Rank
NZ$0.57 B
Marketcap
$6.47
Share price
-5.85%
Change (1 day)
-55.29%
Change (1 year)

Earnings for Verve Therapeutics (VERV)

Earnings in 2024 (TTM): -NZ$0.39 Billion

According to Verve Therapeutics's latest financial reports the company's current earnings are NZ$32.33 Million. a decrease over its 2023 earnings that were of -NZ$0.4 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Verve Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.41 Billion2.48%
2023 -NZ$0.4 Billion34.67%
2022 -NZ$0.3 Billion90.3%
2021 -NZ$0.16 Billion114.31%
2020 -NZ$72.67 Million